Hemostasis Products - Global Market Outlook (2016-2022)

  • ID: 4426418
  • Report
  • Region: Global
  • 158 pages
  • Stratistics Market Research Consulting Pvt Ltd
UP TO OFF
until Jan 31st 2019
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • C. R. Bard, Inc.
  • Chrono-Log Corporation
  • CSL Behring LLC
  • F. Hoffmann-La Roche Ltd.
  • MORE
The Global Hemostasis Products market accounted for $5.78 billion in 2016 and is expected to reach $7.98 billion by 2022 growing at a CAGR of 5.5% during the forecast period 2016 to 2022. This process helps to cease the bleeding and keeps blood within the blood vessel. This procedure is useful in heavy bleeding surgeries and severe wound conditions. Increased rate of introduction in bio-degradable and cost effective market is driving the market. Whereas, high cost structures of Hemostasis product varieties are hampering the market growth.

Advanced Hemostasis & Sealants segment is estimated to have dominant usage in the product type segment because of its cost effectiveness and bi-degradable nature. North American market is estimated to have dominant share in market on account of high healthcare expenditure and technological advancements for providing innovative product. Asia Pacific market is expected to have highest market growth due to medical tourism and surgical procedures.

Some of the key players of the Hemostasis Products market include Abbott Laboratories, Baxter International, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, C. R. Bard, Inc., Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols, S.A., HemCon Medical Technologies, Inc., Integra Life Sciences Corporation, Johnson & Johnson, Medtronic plc, Pfizer, Inc., Siemens AG, Therm-Fisher Scientific, Inc. and Trinity Biotech plc.

End-Users Covered:
  • Clinics
  • Hospitals
Applications Covered:
  • Hemophilia
  • Myocardial Infarction
  • Stroke
  • Surgery
  • Thrombosis
  • Trauma
Product Types Covered:
  • Infusible Hemostasis
  • Fresh Frozen Plasma
  • FVIII Derived from Blood
  • Platelet Concentrates from Donor Blood
  • Prothrombin Complex
  • Topical Hemostasis
  • Collagen
  • Gelatin
  • Oxidized Regenerated Cellulose
  • Polysaccharide
  • Advanced Hemostasis & Sealants
  • Fibrin
  • Flowable
  • Synthetic Sealants
  • Thrombin
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of APAC
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • C. R. Bard, Inc.
  • Chrono-Log Corporation
  • CSL Behring LLC
  • F. Hoffmann-La Roche Ltd.
  • MORE
1. Executive Summary

2. Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3. Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End-User Analysis
3.7 Application Analysis
3.8 Product Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4. Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5. Global Hemostasis Products Market, By End-User
5.1 Introduction
5.2 Clinics
5.3 Hospitals

6. Global Hemostasis Products Market, By Application
6.1 Introduction
6.2 Hemophilia
6.3 Myocardial Infarction
6.4 Stroke
6.5 Surgery
6.6 Thrombosis
6.7 Trauma

7. Global Hemostasis Products Market, By Product Type
7.1 Introduction
7.2 Infusible Hemostasis
7.2.1 Fresh Frozen Plasma
7.2.2 FVIII Derived from Blood
7.2.3 Platelet Concentrates from Donor Blood
7.2.4 Prothrombin Complex
7.3 Topical Hemostasis
7.3.1 Collagen
7.3.2 Gelatin
7.3.3 Oxidized Regenerated Cellulose
7.3.4 Polysaccharide
7.4 Advanced Hemostasis & Sealants
7.4.1 Fibrin
7.4.2 Flowable
7.4.3 Synthetic Sealants
7.4.4 Thrombin

8. Global Hemostasis Products Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9. Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10. Company Profiling
10.1 Abbott Laboratories
10.2 Baxter International, Inc.
10.3 Beckman Coulter, Inc.
10.4 Becton, Dickinson and Company
10.5 C. R. Bard, Inc.
10.6 Chrono-Log Corporation
10.7 CSL Behring LLC
10.8 F. Hoffmann-La Roche Ltd.
10.9 Grifols, S.A.
10.10 HemCon Medical Technologies, Inc.
10.11 Integra LifeSciences Corporation
10.12 Johnson & Johnson
10.13 Medtronic plc
10.14 Pfizer, Inc.
10.15 Siemens AG
10.16 Thermo Fisher Scientific, Inc.
10.17 Trinity Biotech plc.

List of Tables

Table 1 Global Hemostasis Products Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Hemostasis Products Market Outlook, By End-User (2014-2022) ($MN)
Table 3 Global Hemostasis Products Market Outlook, By Clinics (2014-2022) ($MN)
Table 4 Global Hemostasis Products Market Outlook, By Hospitals (2014-2022) ($MN)
Table 5 Global Hemostasis Products Market Outlook, By Application (2014-2022) ($MN)
Table 6 Global Hemostasis Products Market Outlook, By Hemophilia (2014-2022) ($MN)
Table 7 Global Hemostasis Products Market Outlook, By Myocardial Infarction (2014-2022) ($MN)
Table 8 Global Hemostasis Products Market Outlook, By Stroke (2014-2022) ($MN)
Table 9 Global Hemostasis Products Market Outlook, By Surgery (2014-2022) ($MN)
Table 10 Global Hemostasis Products Market Outlook, By Thrombosis (2014-2022) ($MN)
Table 11 Global Hemostasis Products Market Outlook, By Trauma (2014-2022) ($MN)
Table 12 Global Hemostasis Products Market Outlook, By Product Type (2014-2022) ($MN)
Table 13 Global Hemostasis Products Market Outlook, By Infusible Hemostasis (2014-2022) ($MN)
Table 14 Global Hemostasis Products Market Outlook, By Fresh Frozen Plasma (2014-2022) ($MN)
Table 15 Global Hemostasis Products Market Outlook, By FVIII Derived from Blood (2014-2022) ($MN)
Table 16 Global Hemostasis Products Market Outlook, By Platelet Concentrates from Donor Blood (2014-2022) ($MN)
Table 17 Global Hemostasis Products Market Outlook, By Prothrombin Complex (2014-2022) ($MN)
Table 18 Global Hemostasis Products Market Outlook, By Topical Hemostasis (2014-2022) ($MN)
Table 19 Global Hemostasis Products Market Outlook, By Collagen (2014-2022) ($MN)
Table 20 Global Hemostasis Products Market Outlook, By Gelatin (2014-2022) ($MN)
Table 21 Global Hemostasis Products Market Outlook, By Oxidized Regenerated Cellulose (2014-2022) ($MN)
Table 22 Global Hemostasis Products Market Outlook, By Polysaccharide (2014-2022) ($MN)
Table 23 Global Hemostasis Products Market Outlook, By Advanced Hemostasis & Sealants (2014-2022) ($MN)
Table 24 Global Hemostasis Products Market Outlook, By Fibrin (2014-2022) ($MN)
Table 25 Global Hemostasis Products Market Outlook, By Flowable (2014-2022) ($MN)
Table 26 Global Hemostasis Products Market Outlook, By Synthetic Sealants (2014-2022) ($MN)
Table 27 Global Hemostasis Products Market Outlook, By Thrombin (2014-2022) ($MN)
Table 28 North America Hemostasis Products Market Outlook, By Country (2014-2022) ($MN)
Table 29 North America Hemostasis Products Market Outlook, By End-User (2014-2022) ($MN)
Table 30 North America Hemostasis Products Market Outlook, By Clinics (2014-2022) ($MN)
Table 31 North America Hemostasis Products Market Outlook, By Hospitals (2014-2022) ($MN)
Table 32 North America Hemostasis Products Market Outlook, By Application (2014-2022) ($MN)
Table 33 North America Hemostasis Products Market Outlook, By Hemophilia (2014-2022) ($MN)
Table 34 North America Hemostasis Products Market Outlook, By Myocardial Infarction (2014-2022) ($MN)
Table 35 North America Hemostasis Products Market Outlook, By Stroke (2014-2022) ($MN)
Table 36 North America Hemostasis Products Market Outlook, By Surgery (2014-2022) ($MN)
Table 37 North America Hemostasis Products Market Outlook, By Thrombosis (2014-2022) ($MN)
Table 38 North America Hemostasis Products Market Outlook, By Trauma (2014-2022) ($MN)
Table 39 North America Hemostasis Products Market Outlook, By Product Type (2014-2022) ($MN)
Table 40 North America Hemostasis Products Market Outlook, By Infusible Hemostasis (2014-2022) ($MN)
Table 41 North America Hemostasis Products Market Outlook, By Fresh Frozen Plasma (2014-2022) ($MN)
Table 42 North America Hemostasis Products Market Outlook, By FVIII Derived from Blood (2014-2022) ($MN)
Table 43 North America Hemostasis Products Market Outlook, By Platelet Concentrates from Donor Blood (2014-2022) ($MN)
Table 44 North America Hemostasis Products Market Outlook, By Prothrombin Complex (2014-2022) ($MN)
Table 45 North America Hemostasis Products Market Outlook, By Topical Hemostasis (2014-2022) ($MN)
Table 46 North America Hemostasis Products Market Outlook, By Collagen (2014-2022) ($MN)
Table 47 North America Hemostasis Products Market Outlook, By Gelatin (2014-2022) ($MN)
Table 48 North America Hemostasis Products Market Outlook, By Oxidized Regenerated Cellulose (2014-2022) ($MN)
Table 49 North America Hemostasis Products Market Outlook, By Polysaccharide (2014-2022) ($MN)
Table 50 North America Hemostasis Products Market Outlook, By Advanced Hemostasis & Sealants (2014-2022) ($MN)
Table 51 North America Hemostasis Products Market Outlook, By Fibrin (2014-2022) ($MN)
Table 52 North America Hemostasis Products Market Outlook, By Flowable (2014-2022) ($MN)
Table 53 North America Hemostasis Products Market Outlook, By Synthetic Sealants (2014-2022) ($MN)
Table 54 North America Hemostasis Products Market Outlook, By Thrombin (2014-2022) ($MN)
Table 55 Europe Hemostasis Products Market Outlook, By Country (2014-2022) ($MN)
Table 56 Europe Hemostasis Products Market Outlook, By End-User (2014-2022) ($MN)
Table 57 Europe Hemostasis Products Market Outlook, By Clinics (2014-2022) ($MN)
Table 58 Europe Hemostasis Products Market Outlook, By Hospitals (2014-2022) ($MN)
Table 59 Europe Hemostasis Products Market Outlook, By Application (2014-2022) ($MN)
Table 60 Europe Hemostasis Products Market Outlook, By Hemophilia (2014-2022) ($MN)
Table 61 Europe Hemostasis Products Market Outlook, By Myocardial Infarction (2014-2022) ($MN)
Table 62 Europe Hemostasis Products Market Outlook, By Stroke (2014-2022) ($MN)
Table 63 Europe Hemostasis Products Market Outlook, By Surgery (2014-2022) ($MN)
Table 64 Europe Hemostasis Products Market Outlook, By Thrombosis (2014-2022) ($MN)
Table 65 Europe Hemostasis Products Market Outlook, By Trauma (2014-2022) ($MN)
Table 66 Europe Hemostasis Products Market Outlook, By Product Type (2014-2022) ($MN)
Table 67 Europe Hemostasis Products Market Outlook, By Infusible Hemostasis (2014-2022) ($MN)
Table 68 Europe Hemostasis Products Market Outlook, By Fresh Frozen Plasma (2014-2022) ($MN)
Table 69 Europe Hemostasis Products Market Outlook, By FVIII Derived from Blood (2014-2022) ($MN)
Table 70 Europe Hemostasis Products Market Outlook, By Platelet Concentrates from Donor Blood (2014-2022) ($MN)
Table 71 Europe Hemostasis Products Market Outlook, By Prothrombin Complex (2014-2022) ($MN)
Table 72 Europe Hemostasis Products Market Outlook, By Topical Hemostasis (2014-2022) ($MN)
Table 73 Europe Hemostasis Products Market Outlook, By Collagen (2014-2022) ($MN)
Table 74 Europe Hemostasis Products Market Outlook, By Gelatin (2014-2022) ($MN)
Table 75 Europe Hemostasis Products Market Outlook, By Oxidized Regenerated Cellulose (2014-2022) ($MN)
Table 76 Europe Hemostasis Products Market Outlook, By Polysaccharide (2014-2022) ($MN)
Table 77 Europe Hemostasis Products Market Outlook, By Advanced Hemostasis & Sealants (2014-2022) ($MN)
Table 78 Europe Hemostasis Products Market Outlook, By Fibrin (2014-2022) ($MN)
Table 79 Europe Hemostasis Products Market Outlook, By Flowable (2014-2022) ($MN)
Table 80 Europe Hemostasis Products Market Outlook, By Synthetic Sealants (2014-2022) ($MN)
Table 81 Europe Hemostasis Products Market Outlook, By Thrombin (2014-2022) ($MN)
Table 82 Asia Pacific Hemostasis Products Market Outlook, By Country (2014-2022) ($MN)
Table 83 Asia Pacific Hemostasis Products Market Outlook, By End-User (2014-2022) ($MN)
Table 84 Asia Pacific Hemostasis Products Market Outlook, By Clinics (2014-2022) ($MN)
Table 85 Asia Pacific Hemostasis Products Market Outlook, By Hospitals (2014-2022) ($MN)
Table 86 Asia Pacific Hemostasis Products Market Outlook, By Application (2014-2022) ($MN)
Table 87 Asia Pacific Hemostasis Products Market Outlook, By Hemophilia (2014-2022) ($MN)
Table 88 Asia Pacific Hemostasis Products Market Outlook, By Myocardial Infarction (2014-2022) ($MN)
Table 89 Asia Pacific Hemostasis Products Market Outlook, By Stroke (2014-2022) ($MN)
Table 90 Asia Pacific Hemostasis Products Market Outlook, By Surgery (2014-2022) ($MN)
Table 91 Asia Pacific Hemostasis Products Market Outlook, By Thrombosis (2014-2022) ($MN)
Table 92 Asia Pacific Hemostasis Products Market Outlook, By Trauma (2014-2022) ($MN)
Table 93 Asia Pacific Hemostasis Products Market Outlook, By Product Type (2014-2022) ($MN)
Table 94 Asia Pacific Hemostasis Products Market Outlook, By Infusible Hemostasis (2014-2022) ($MN)
Table 95 Asia Pacific Hemostasis Products Market Outlook, By Fresh Frozen Plasma (2014-2022) ($MN)
Table 96 Asia Pacific Hemostasis Products Market Outlook, By FVIII Derived from Blood (2014-2022) ($MN)
Table 97 Asia Pacific Hemostasis Products Market Outlook, By Platelet Concentrates from Donor Blood (2014-2022) ($MN)
Table 98 Asia Pacific Hemostasis Products Market Outlook, By Prothrombin Complex (2014-2022) ($MN)
Table 99 Asia Pacific Hemostasis Products Market Outlook, By Topical Hemostasis (2014-2022) ($MN)
Table 100 Asia Pacific Hemostasis Products Market Outlook, By Collagen (2014-2022) ($MN)
Table 101 Asia Pacific Hemostasis Products Market Outlook, By Gelatin (2014-2022) ($MN)
Table 102 Asia Pacific Hemostasis Products Market Outlook, By Oxidized Regenerated Cellulose (2014-2022) ($MN)
Table 103 Asia Pacific Hemostasis Products Market Outlook, By Polysaccharide (2014-2022) ($MN)
Table 104 Asia Pacific Hemostasis Products Market Outlook, By Advanced Hemostasis & Sealants (2014-2022) ($MN)
Table 105 Asia Pacific Hemostasis Products Market Outlook, By Fibrin (2014-2022) ($MN)
Table 106 Asia Pacific Hemostasis Products Market Outlook, By Flowable (2014-2022) ($MN)
Table 107 Asia Pacific Hemostasis Products Market Outlook, By Synthetic Sealants (2014-2022) ($MN)
Table 108 Asia Pacific Hemostasis Products Market Outlook, By Thrombin (2014-2022) ($MN)
Table 109 RoW Hemostasis Products Market Outlook, By Country (2014-2022) ($MN)
Table 110 RoW Hemostasis Products Market Outlook, By End-User (2014-2022) ($MN)
Table 111 RoW Hemostasis Products Market Outlook, By Clinics (2014-2022) ($MN)
Table 112 RoW Hemostasis Products Market Outlook, By Hospitals (2014-2022) ($MN)
Table 113 RoW Hemostasis Products Market Outlook, By Application (2014-2022) ($MN)
Table 114 RoW Hemostasis Products Market Outlook, By Hemophilia (2014-2022) ($MN)
Table 115 RoW Hemostasis Products Market Outlook, By Myocardial Infarction (2014-2022) ($MN)
Table 116 RoW Hemostasis Products Market Outlook, By Stroke (2014-2022) ($MN)
Table 117 RoW Hemostasis Products Market Outlook, By Surgery (2014-2022) ($MN)
Table 118 RoW Hemostasis Products Market Outlook, By Thrombosis (2014-2022) ($MN)
Table 119 RoW Hemostasis Products Market Outlook, By Trauma (2014-2022) ($MN)
Table 120 RoW Hemostasis Products Market Outlook, By Product Type (2014-2022) ($MN)
Table 121 RoW Hemostasis Products Market Outlook, By Infusible Hemostasis (2014-2022) ($MN)
Table 122 RoW Hemostasis Products Market Outlook, By Fresh Frozen Plasma (2014-2022) ($MN)
Table 123 RoW Hemostasis Products Market Outlook, By FVIII Derived from Blood (2014-2022) ($MN)
Table 124 RoW Hemostasis Products Market Outlook, By Platelet Concentrates from Donor Blood (2014-2022) ($MN)
Table 125 RoW Hemostasis Products Market Outlook, By Prothrombin Complex (2014-2022) ($MN)
Table 126 RoW Hemostasis Products Market Outlook, By Topical Hemostasis (2014-2022) ($MN)
Table 127 RoW Hemostasis Products Market Outlook, By Collagen (2014-2022) ($MN)
Table 128 RoW Hemostasis Products Market Outlook, By Gelatin (2014-2022) ($MN)
Table 129 RoW Hemostasis Products Market Outlook, By Oxidized Regenerated Cellulose (2014-2022) ($MN)
Table 130 RoW Hemostasis Products Market Outlook, By Polysaccharide (2014-2022) ($MN)
Table 131 RoW Hemostasis Products Market Outlook, By Advanced Hemostasis & Sealants (2014-2022) ($MN)
Table 132 RoW Hemostasis Products Market Outlook, By Fibrin (2014-2022) ($MN)
Table 133 RoW Hemostasis Products Market Outlook, By Flowable (2014-2022) ($MN)
Table 134 RoW Hemostasis Products Market Outlook, By Synthetic Sealants (2014-2022) ($MN)
Table 135 RoW Hemostasis Products Market Outlook, By Thrombin (2014-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • C. R. Bard, Inc.
  • Chrono-Log Corporation
  • CSL Behring LLC
  • F. Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • HemCon Medical Techn
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll